BackgroundIgG anti-spike (S) antibodies arise after SARS-CoV-2 infection as well as vaccination. Levels of IgG anti-S are linked to neutralizing antibody titers and protection against (re)infection. M
Longitudinal serum samples taken at 3, 6, 12 and 18 months post-symptom onset from two primary DENV-1, one primary DENV-2, two primary DENV-3, and one secondary DENV-2 infection were obtained from nat
Background: COVID-19 is a global pandemic that affected millions of people all over the world since 2019. Infection with COVID-19 initiates a humoral immune response that produces antibodies against s